Does ADAGRASIB Cause Electrocardiogram qt prolonged? 16 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 16 reports of Electrocardiogram qt prolonged have been filed in association with ADAGRASIB (KRAZATI). This represents 1.8% of all adverse event reports for ADAGRASIB.
16
Reports of Electrocardiogram qt prolonged with ADAGRASIB
1.8%
of all ADAGRASIB reports
2
Deaths
7
Hospitalizations
How Dangerous Is Electrocardiogram qt prolonged From ADAGRASIB?
Of the 16 reports, 2 (12.5%) resulted in death, 7 (43.8%) required hospitalization, and 3 (18.8%) were considered life-threatening.
Is Electrocardiogram qt prolonged Listed in the Official Label?
Yes, Electrocardiogram qt prolonged is listed as a known adverse reaction in the official FDA drug label for ADAGRASIB.
What Other Side Effects Does ADAGRASIB Cause?
Death (272)
Diarrhoea (113)
Hospitalisation (108)
Nausea (87)
Vomiting (79)
Off label use (70)
Asthenia (61)
Fatigue (51)
Decreased appetite (43)
Dehydration (35)
What Other Drugs Cause Electrocardiogram qt prolonged?
QUETIAPINE (1,869)
OLANZAPINE (1,325)
RIBOCICLIB (1,020)
AMIODARONE (1,000)
HYDROXYCHLOROQUINE (992)
CLOZAPINE (958)
CITALOPRAM HYDROBROMIDE (917)
ESCITALOPRAM OXALATE (899)
ONDANSETRON (881)
BUPROPION (853)
Which ADAGRASIB Alternatives Have Lower Electrocardiogram qt prolonged Risk?
ADAGRASIB vs ADALIMUMAB
ADAGRASIB vs ADALIMUMAB-AACF
ADAGRASIB vs ADALIMUMAB-AATY
ADAGRASIB vs ADALIMUMAB-ADAZ
ADAGRASIB vs ADALIMUMAB-ADBM